ACCOLADE
Device
Stryker Corporation
Total Payments
$140.9M
Transactions
19,696
Doctors
5,619
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $24.8M | 967 | 509 |
| 2023 | $23.4M | 1,740 | 764 |
| 2022 | $19.9M | 3,172 | 1,321 |
| 2021 | $20.5M | 2,688 | 1,310 |
| 2020 | $15.2M | 1,887 | 919 |
| 2019 | $17.5M | 3,494 | 1,544 |
| 2018 | $19.4M | 4,265 | 1,636 |
| 2017 | $87,110 | 1,483 | 822 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $133.3M | 537 | 94.6% |
| Unspecified | $4.1M | 90 | 2.9% |
| Consulting Fee | $2.1M | 536 | 1.5% |
| Food and Beverage | $784,152 | 17,174 | 0.6% |
| Travel and Lodging | $425,511 | 1,267 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $145,571 | 30 | 0.1% |
| Education | $9,827 | 59 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,120 | 2 | 0.0% |
| Gift | $89.00 | 1 | 0.0% |
Payments by Type
General
$136.8M
19,606 transactions
Research
$4.1M
90 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CLINICAL OUTCOMES REPORTING STUDY | Stryker Corporation | $2.4M | 0 |
| CLINICAL OUTCOMES RESEARCH REGISTRY REPORTING INITIATIVE (AT EMORY) | Stryker Corporation | $727,304 | 0 |
| CLINICAL OUTCOMES RESEARCH REGISTRY REPORTING INITIATIVE AT EMORY | Stryker Corporation | $364,233 | 0 |
| CLINICAL OUTCOMES OF ROBOTIC ARM ASSISTED TOTAL HIP REPLACEMENT WITH MINIMUM TWO YEAR FOLLOW UP | Stryker Corporation | $191,600 | 0 |
| 5YEAR FOLLOW UP OF THE ACCOLADE II STEM | Stryker Corporation | $117,777 | 0 |
| 5-YEAR FOLLOW-UP OF THE ACCOLADE II STEM | Stryker Corporation | $94,277 | 0 |
| RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP STEM | Stryker Corporation | $57,041 | 2 |
| SHORT TO MIDTERM FOLLOW UP OF ACCOLADE II AND MDM METAL ION AND DEXA ANALYSIS | Stryker Corporation | $56,844 | 0 |
| SHORT TO MIDTERM FOLLOW-UP OF ACCOLADE II AND MDM METAL ION AND DEXA ANALYSIS | Stryker Corporation | $54,439 | 0 |
| EARLY OUTCOMES OF CEMENTED VERSUS CEMENTLESS TOTAL KNEE ARTHROPLASTY USING THE TRIATHLON KNEE | Stryker Corporation | $19,081 | 0 |
| A RETROSPECTIVE COMPARATIVE ANALYSIS OF OUTCOMES OF FIRST TWENTY CASES WITH DIRECT SUPERIOR/ TRANSPIRIFORMIS APPROACH VERSUS THE NEXT TWENTY CASES WITH DIRECT SUPERIOR/TRANSPIRIFORMIS APPROACH DURING TOTAL HIP ARTHROPLASTY | Stryker Corporation | $18,151 | 0 |
| A RETROSPECTIVE CASE-CONTROLLED COMPARATIVE ANALYSIS OF OUTCOMES OF TWENTY CASES WITH DIRECT SUPERIOR APPROACH (AFTER LEARNING CURVE) VERSUS TWENTY CASES WITH MINI POSTERIOR APPROACH DURING TOTAL HIP ARTHROPLASTY | Stryker Corporation | $13,720 | 0 |
| A RETROSPECTIVE COMPARATIVE ANALYSIS OF OUTCOMES OF FIRST TWENTY CASES WITH DIRECT SUPERIOR TRANSPIRIFORMIS APPROACH VERSUS THE NEXT TWENTY CASES WITH DIRECT SUPERIORTRANSPIRIFORMIS APPROACH DURING TOTAL HIP ARTHROPLASTY | Stryker Corporation | $10,571 | 0 |
| RADIOGRAPHIC FIXATION OF THE 3D PRINTED TRIDENT II TRITANIUM ACETABULAR SYSTEM IN PRIMARY TOTAL HIP ARTHROPLASTY | Stryker Corporation | $10,094 | 0 |
| ACCURACY OF ROBOTICARM ASSISTED THA COMPARED TO MANUAL CONVENTIONAL THA | Stryker Corporation | $8,370 | 0 |
| RESTORATION; ANATOMIC DUAL MOBILITY (ADM) X3; ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE; II HIP STEM | Stryker Corporation | $7,860 | 2 |
| METAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECUR-FIT ADVANCED STEMS | Stryker Corporation | $3,000 | 0 |
| A LONGITUDINAL MULTICENTER STUDY OF ROBOTIC ARM ASSISTED THA: ACETABULAR CUP PLACEMENT ACCURACY AND CLINICAL OUTCOMES | Stryker Corporation | $2,508 | 0 |
| METAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANCED STEMS | Stryker Corporation | $2,000 | 0 |
Top Doctors Receiving Payments for ACCOLADE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Orthopaedic Surgery | Philadelphia, PA | $9.4M | 49 |
| , MD | Orthopaedic Surgery | Athens, GA | $9.3M | 32 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Saint Louis, MO | $9.3M | 36 |
| , M.D | Orthopaedic Surgery | Phoenix, AZ | $8.2M | 26 |
| William Maloney | Orthopaedic Surgery | Palo Alto, CA | $8.0M | 37 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Cleveland, OH | $7.7M | 40 |
| , MD | Orthopaedic Surgery | Cleveland, OH | $7.4M | 38 |
| , MD | Orthopaedic Surgery | Charlotte, NC | $7.4M | 44 |
| , M.D | Orthopaedic Surgery | Temple, TX | $7.2M | 35 |
| , M.D | Orthopaedic Surgery | Sartell, MN | $5.8M | 97 |
| , M.D | Specialist | Cleveland, OH | $5.7M | 35 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Ypsilanti, MI | $5.5M | 30 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Boston, MA | $5.1M | 41 |
| , M.D | Orthopaedic Surgery | New York, NY | $5.0M | 41 |
| , MD | Orthopaedic Surgery | Greenwood, IN | $4.8M | 56 |
| , MD | Orthopaedic Surgery | Charlotte, NC | $4.5M | 34 |
| Antonio Orraca-Gotay | — | San Juan, PR | $4.4M | 131 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Rochester, MN | $3.6M | 17 |
| , MD | Orthopaedic Surgery | Cleveland, OH | $3.2M | 21 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Rochester, MN | $2.9M | 31 |
| , MD | Orthopaedic Surgery | Oakland, CA | $2.3M | 23 |
| , MD | Orthopaedic Surgery | New York, NY | $2.2M | 16 |
| , M.D., M.SC | Adult Reconstructive Orthopaedic Surgery | Chicago, IL | $2.2M | 26 |
| , MD | Orthopaedic Surgery | Rochester, MN | $2.1M | 34 |
| Anthony Hedley | — | Phoenix, AZ | $1.7M | 10 |
Ad
Manufacturing Companies
- Stryker Corporation $140.8M
- BOSTON SCIENTIFIC CORPORATION $51,926
- Boston Scientific Corporation $29,776
Product Information
- Type Device
- Total Payments $140.9M
- Total Doctors 5,619
- Transactions 19,696
About ACCOLADE
ACCOLADE is a device associated with $140.9M in payments to 5,619 healthcare providers, recorded across 19,696 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2017 to 2024. In 2024, $24.8M was paid across 967 transactions to 509 doctors.
The most common payment nature for ACCOLADE is "Royalty or License" ($133.3M, 94.6% of total).
ACCOLADE is associated with 19 research studies, including "CLINICAL OUTCOMES REPORTING STUDY" ($2.4M).